This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
GlaxoSmithKline extends preferential pricing. Pharmacoecon. Outcomes News 319, 11 (2001). https://doi.org/10.1007/BF03269435
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269435